JP Morgan Maintains Overweight on PACS Group, Raises Price Target to $58

Benzinga · 3d ago
JP Morgan analyst Benjamin Rossi maintains PACS Group (NYSE:PACS) with a Overweight and raises the price target from $47 to $58.